Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China
Ke Ma,Zhixiang Cheng,Hao Jiang,Zhangya Lin,Chuansheng Liu,Xianguo Liu,Lijuan Lu,Yan Lu,Wei Tao,Suoliang Wang,Xiaoqiu Yang,Qishan Yi,Xiaomei Zhang,Ying Zhang,Yanqing Liu
DOI: https://doi.org/10.2147/jpr.s445171
IF: 2.8319
2024-03-09
Journal of Pain Research
Abstract:Ke Ma, 1, &ast Zhixiang Cheng, 2, &ast Hao Jiang, 3, &ast Zhangya Lin, 4, &ast Chuansheng Liu, 5, &ast Xianguo Liu, 6, &ast Lijuan Lu, 7, &ast Yan Lu, 8, &ast Wei Tao, 9, &ast Suoliang Wang, 10, &ast Xiaoqiu Yang, 11, &ast Qishan Yi, 12, &ast Xiaomei Zhang, 13, &ast Ying Zhang, 14, &ast Yanqing Liu 15, &ast 1 Department of Algology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Algology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China; 3 Department of Algology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 4 Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 5 Department of Algology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 6 Pain Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China; 7 Department of Pain Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China; 8 Department of Algology, Xijing Hospital, The Fourth Military Medical University, Xian, People's Republic of China; 9 Department of Neurosurgery, Shenzhen University General Hospital, Shenzhen, People's Republic of China; 10 Department of Algology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China; 11 Department of Algology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 12 Department of Algology, The Yibin First People's Hospital Affiliated Chongqing Medical University, Yibin, People's Republic of China; 13 Department of Algology, The First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China; 14 Department of Algology. Hospital (T.C.M) Affiliated to Southwest Medical University, Luzhou, People's Republic of China; 15 Department of Algology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ke Ma, Department of Algology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University school of medicine, Shanghai, 200092, People's Republic of China, Tel +86133618792160, Email Yanqing Liu, Department of Algology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China, Tel +8618601203409, Email Ion channel drugs have been increasing used for chronic pain management with progress in the development of selective calcium channel modulators. Although ion channel drugs have been proven safe and effective in clinical practice, uncertainty remains regarding its use to treat chronic pain. To standardize the clinical practice of ion channel drug for the treatment of chronic pain, the National Health Commission Capacity Building and Continuing Education Center for Pain Diagnosis and Treatment Special Ability Training Project established an expert group to form an expert consensus on the use of ion channel drugs for the treatment of chronic pain after repeated discussions on existing medical evidence combined with the well clinical experience of experts. The consensus provided information on the mechanism of action of ion channel drugs and their recommendations, caution use, contraindications, and precautions for their use in special populations to support doctors in their clinical decision-making. Keywords: chronic pain, ion channel drugs, voltage-gated calcium channels, voltage-gated sodium channel Chronic pain is defined as pain that persists for ≥3 months. The International Society for Pain (IASP) classifies chronic pain into two categories: chronic primary and secondary pain syndromes. 1 Currently, there is relatively few epidemiological data regarding the prevalence of chronic pain according to the IASP classification in the 11th edition of the International Classification of Diseases (ICD-11). In 2019, Wang et al 2 conducted a preliminary survey of 1545 patients with chronic pain according to the IASP ICD-11 chronic pain classification in five tertiary general hospitals in three provinces and four regions in C -Abstract Truncated-
clinical neurology